Medical Biosensors Are Moving To The Point-of-Care (Wearable USA 2017)

Medical biosensors are used to diagnose a wealth of diseases and health conditions, including cardiovascular issues, infectious diseases and cancer. Increasingly, biosensors are also being used to achieve targeted therapies in precision medicine and increase the efficacy of drugs through pharmacogenomics. There is a growing trend for these medical biosensors to be closer to the patient at the point-of-care, enabled by several advances in technologies including device miniaturization and rapid nucleic acid amplification techniques. This presentation will give an overview of the important trends in the field of medical biosensors, and the new technologies and devices which are likely to be highly disruptive to the in vitro diagnostics market.

Laura Baers obtained a PhD in Biochemistry at the University of Cambridge. Laura's PhD research focused on biotechnology and synthetic biology approaches to engineer photosynthetic organisms with beneficial traits. Outcomes for this work have been published in leading peer-reviewed journals, and presented at conferences globally.

 

Prior to her PhD, Laura conducted research into photosynthesis and heavy metal toxicity in plants at Imperial College London and the University of Southampton, where she gained a first class degree in Biology.

IDTechEx provides independent market research, business intelligence and events on emerging technologies to companies across the value chain. Our clients use our insights to help make strategic business decisions and grow their organizations.

 

IDTechEx business and technology experts provide international perspective in a diverse range of emerging technologies including 3D printing, electric vehicles, energy harvesting, energy storage, life sciences, printed electronics, IoT and many other topics.

 

IDTechEx is headquartered in Cambridge, UK with additional offices in USA, Germany and Japan and associates in South Korea.